FDA chief explains changes to “black box” warnings on some hormone therapies for menopause

November 10, 2025
3,398 Views

FDA commissioner Dr. Marty Makary joins “CBS Mornings” to discuss the agency’s announcement Thursday that boxed warnings will be removed from many estrogen products used for hormone therapy, a treatment that helps alleviate the symptoms of menopause.

Source link

You may be interested

Lung Transplant | American Lung Association
Health
shares3,552 views
Health
shares3,552 views

Lung Transplant | American Lung Association

new admin - Dec 05, 2025

As with any chronic medical condition, your pulmonary (lung) condition could reach a point of debilitation often known as end-stage,…

Inside Killhouse Academy, where Ukraine’s fighters learn to fly drones
Top Stories
shares3,234 views
Top Stories
shares3,234 views

Inside Killhouse Academy, where Ukraine’s fighters learn to fly drones

new admin - Dec 05, 2025

In a disused warehouse at an undisclosed location in Ukraine, a military drone instructor who goes by the call sign…

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health
Health
shares3,019 views
Health
shares3,019 views

Medical Device Safety Action Plan: Protecting Patients, Promoting Public Health

new admin - Dec 05, 2025

The FDA’s Center for Devices and Radiological Health (CDRH)'s vision for medical device safety is to protect patients and spur…